Valneva SE (VALN) Gross Margin Growth (1y) (2022 - 2026)

Valneva SE (VALN) Gross Margin Growth (1y) (2022 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Gross Margin Growth (1y) (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn - -
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn - -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn 372.00
4 NuCana 279.75 Bn 279.75 Bn - -
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn -5.00
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn -165.00
7 Belite Bio 62.51 Bn 62.51 Bn - -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn 236.00
9 Revolution Medicines 37.78 Bn 37.78 Bn - -
10 Valneva SE 803.90 Mn 680.66 Mn 5.38 Mn -3,791.00

Historic Data

Download Data
DateValue
Mar 31, 2026 -3,791.00
Dec 31, 2025 -4,008.00
Sep 30, 2025 -4,787.00
Jun 30, 2025 1,176.00
Mar 31, 2025 2,085.00
Dec 31, 2024 860.00
Sep 30, 2024 -651.00
Jun 30, 2024 2,125.00
Mar 31, 2024 -654.00
Dec 31, 2023 4,705.00
Sep 30, 2023 -3,514.00
Jun 30, 2023 13,792.00
Mar 31, 2023 232.00
Dec 31, 2022 -9,908.00
Sep 30, 2022 53,861.00
Jun 30, 2022 -13,795.00
Mar 31, 2022 -34.00